UK

United Kingdom · Research and development · C-Suite (20+ years)

Chief Medical Officer

Here is the whole job, in plain words. What it is, what you decide, how you're judged, how people get here and where they go next. Then the part no course gives you: twelve AI tutors who learn your work.

See how AI is changing this job, and get the full read by email.

Start my free Automation Fluency module

As a Chief Medical Officer, a good place to start on AI & Machine Learning in Drug Discovery & Development is Planning Automation Across a Department, a free Future Fluency module at Level 5. You'd practise working out what in your department's work could be automated, what should not be, and what to recommend.

Free to start, no card.

Keep this job description

Where should we send it?

One email: what AI is changing in this job, the new skills it asks for, where it leads, and where to start free. With a link back here. Nothing else follows unless you confirm your address.

Your employer, or 'self-employed'

Leading a team? Try this with up to five of them for 14 days, free.

  • Experience bandC-Suite (20+ years)
  • Reports toChief Executive Officer (CEO)
  • UK framework levelUsually an executive or board-level role

Also advertised as Chief Scientific Officer (CSO) · EVP, Global Research & Development · Head of Enterprise Medical Strategy

Built on 43,079 real UK job descriptions we analysed · grounded in what real qualifications cover

Two short quizzes about you

1From this job to a course

The qualifications matched to this job

ETCAL Level 3 Diploma in Laboratory and Associated Technical Activities ETC Awards Limited · Level 3 · covers 1 of 1 standard
EAL Level 3 NVQ Diploma in Providing Electronic Fire and Security Systems Excellence, Achievement & Learning Limited · Level 3 · covers 1 of 1 standard

Matched from the standards this job is measured against: a suggestion, not an official ruling.

The units you would start with

Provide scientific or technical leadership for a workplace team ETCAL Level 3 Diploma in Laboratory and Associated Technical Activities
Provide leadership for your team EAL Level 3 NVQ Diploma in Providing Electronic Fire and Security Systems

The future skills this job leans on

AI Fluency working with AI as a thinking partner
Data Fluency turning numbers into a decision
AI Governance Fluency using AI responsibly
Automation Fluency building AI into how work runs
Foresight Fluency seeing round the corner
Your Plan Illustration

Built for Chief Medical Officer

2 units that map to this job, from the qualifications that cover it.

  1. Provide scientific or technical leadership for a workplace team ETC Awards Limited · covers 1 of 1 standards Level 3
  2. Provide leadership for your team Excellence, Achievement & Learning Limited · covers 1 of 1 standards Level 3
These are the real units behind this job, in the order they rank for it. Nothing here is marked done, because this plan has not been started by anyone yet. Yours would fill in as you go.

2AI and this work

Will AI change your work as a Chief Medical Officer?

Nobody can say exactly how. Here is what this job is being asked for next, and where to start.

The new skills this role is being asked for

  • AI & Machine Learning in Drug Discovery & Development
  • Personalised Medicine & Precision Health Strategy
Why each one is rising

The future skills this job leans on

We'll only ever tell you what we can actually back up. No hype, no scare tactics.

What happens when you start

Next, a free account. We build your Chief Medical Officer plan as you set up, starting with the free Automation Fluency module. No card.

Your first Future Fluency module is free. After that, your AI tutor is £70 a month.

Ready to pay? Subscribe for £70 a month

Keep this read. One email with what AI is changing in this job, the new skills it asks for and where to start free. Nothing else follows unless you confirm your address.

3What this role really is

A Chief Medical Officer sets the medical and scientific direction for a company's research and clinical work over several years.

4What you'd actually use

The tools this job runs on, and how well you'd need to know each one.

Veeva Medical CRM (Strategic) Strategic

Defining the overarching strategy for KOL engagement data capture, ensuring compliance, and extracting high-level insights for R&D portfolio decisions. You're not logging calls, but you're setting the standards for how the data informs strategy.

Clinical Trial Management Systems (Architect) Architect

Using aggregated data from systems like Medidata Rave or Oracle Clinical to make strategic decisions on trial placement, resource allocation, and overall pipeline health. You'll be using the analytics to forecast and plan, not managing individual sites.

Scientific Literature Databases (Strategic) Strategic

Leveraging meta-analysis and publication trend data (from PubMed, Scopus, Embase) to inform long-term R&D strategy, identify emerging therapeutic areas, and assess competitive landscapes.

Executive Planning Software (e.g., Anaplan, Workday Adaptive Planning) Expert

Building, managing, and defending the entire R&D budget, modelling resource allocation scenarios across the portfolio, and presenting financial plans to the CEO and Board.

Collaboration Suites (e.g., MS Teams, Confluence) (Strategic) Strategic

Defining the communication architecture, knowledge management strategy, and governance for the entire global R&D and Medical Affairs functions, ensuring seamless information flow across a vast organisation.

5What you get to decide, and how that grows

Power in a job isn't your title. It's what you're allowed to decide. Here's how it grows as you move up.

The choiceComing in Where you are nowThe step above
Enterprise R&D Strategy N/A N/A N/A
Major Clinical Trial Design & Execution N/A N/A N/A
R&D Budget Allocation (£10M+) N/A N/A N/A
Regulatory Agency Engagement Strategy N/A N/A N/A
M&A Scientific Due Diligence N/A N/A N/A

6How you'll be judged

The scoreboard, and what is not on it. The hard targets, how often each is actually looked at, and the quiet signals that never reach a dashboard.

R&D Pipeline Progression Rate
The percentage of drug candidates that successfully move from one development phase to the next (e.g., pre-clinical to Phase 1, Phase 2 to Phase 3).
Target · Achieve 10-15% improvement in phase transition success rates over industry average.

If the industry average for Phase 2 to Phase 3 transition is 30%, your target might be to hit 33-34.5% for our key assets, showing superior scientific and clinical strategy.

Key Regulatory Approvals & Milestones
Successful submission and approval of Investigational New Drug (IND) applications, Marketing Authorisation Applications (MAA), and other critical regulatory milestones.
Target · Achieve 100% of planned regulatory submissions on time and secure ≥90% of expected approvals within target timelines.

Successfully securing a Conditional Marketing Authorisation from the EMA for our lead oncology asset within 18 months of submission, hitting the critical market entry window.

R&D Budget Efficiency (P&L Impact)
The effectiveness of R&D spend in generating value, measured against projected returns and actual project costs.
Target · Maintain R&D spend within 5% of approved annual budget, demonstrating a clear ROI for key projects.

Delivering a Phase 3 trial programme for £200M when the initial budget was £210M, without compromising data quality or timelines, showing excellent financial stewardship.

Scientific Publication & Presentation Impact
The quantity and quality of scientific output (peer-reviewed publications, major congress presentations) originating from our research.
Target · Increase the company's scientific impact factor by 10% year-on-year, measured by citations and presence at Tier 1 congresses.

Publishing two papers in high-impact journals (e.g., NEJM, Lancet) and having our data presented as a plenary session at ASCO, significantly boosting our scientific credibility.

Investor Confidence & Scientific Narrative
The ability to articulate our scientific vision and pipeline strength to investors, influencing market perception and share price.
  • Positive feedback from investor calls and roadshows
  • analysts' reports consistently reflecting a strong scientific story
  • increased investor engagement in R&D updates
  • successful capital raises based on scientific vision.
Regulatory Body Relationships
Building and maintaining robust, trust-based relationships with key global regulatory agencies.
  • Proactive engagement in scientific advice meetings
  • smooth and collaborative interactions during inspections
  • early identification and mitigation of potential regulatory hurdles
  • positive feedback from regulatory counterparts.
Scientific Community & KOL Credibility
The company's standing and influence within the broader scientific and medical community, particularly with Key Opinion Leaders.
  • KOLs actively seeking collaboration with us
  • invitations to participate in external scientific advisory boards
  • positive reputation at major medical congresses
  • our scientists being recognised for their contributions.
Talent Attraction & Retention in R&D
The ability to attract, develop, and retain top scientific and medical talent within the R&D organisation.
  • Low voluntary turnover rates for high-performing R&D staff
  • successful recruitment of senior scientific leaders
  • positive internal feedback on career development opportunities
  • our R&D team being seen as a 'destination' for top talent.

7Would you like it

Both sides. What people enjoy, and what grinds them down.

What people enjoy
Shaping the Future of Medicine

You're driven by the opportunity to identify and bring forward truly innovative therapies that change patient outcomes. This shows up in your relentless pursuit of scientific excellence, your willingness to invest in groundbreaking research, and your focus on long-term impact rather than quarterly results.

You'll spend hours reviewing early-stage research, not just for its commercial potential, but for its genuine scientific merit and potential to address unmet medical needs, pushing your teams to think bigger.

Building a Legacy of Scientific Excellence

You want to leave a lasting mark on the company and the industry. This means fostering a culture of scientific rigour, mentoring the next generation of R&D leaders, and ensuring the company is recognised globally for its contributions to science. You're building an institution, not just running a department.

You'll champion internal scientific awards, ensure our researchers present at top conferences, and actively recruit leading scientists, all to elevate our collective scientific reputation.

Navigating Complex Challenges

The sheer complexity of drug development, from scientific hurdles to regulatory mazes and market pressures, energises you. You thrive on solving multi-faceted problems that have no easy answers, enjoying the intellectual challenge of orchestrating a global R&D effort.

When a new regulatory guidance comes out that impacts a key programme, you'll be the first to dive into the details, bringing together legal, clinical, and scientific teams to craft a compliant and effective strategy.

What frustrates people
  • The slow pace of regulatory review, even for breakthrough therapies, can be maddening.
  • Balancing the urgent need for quarterly results with the inherently long-term nature of R&D.
  • Managing internal politics and conflicting priorities across different business units.
  • The constant pressure to justify significant R&D spend to a financially focused Board.
  • The sheer volume of information and decisions you're expected to oversee, it's like drinking from a firehose daily.
  • Dealing with the fallout when a promising drug candidate fails in late-stage trials – it's emotionally and financially taxing.
What this role does not give you
  • A quiet, predictable work environment with minimal external pressure.
  • The opportunity to be hands-on in the lab or directly involved in patient care (that's long in the past).
  • A role where you can avoid difficult conversations or making unpopular decisions.
  • A clear, linear path where every project you champion comes to fruition.

8Who you work with

This role has enterprise-wide impact, directly shaping the company's scientific direction, product pipeline, market positioning, and long-term financial health. The CMO's decisions dictate where significant R&D investment goes and ultimately determines which new medicines make it to patients. It's about setting the scientific compass for the entire organisation.

Inside the business
  • CEO and Executive Leadership Team (ELT)
  • Board of Directors
  • Head of Commercial/Chief Revenue Officer
  • Chief Financial Officer
  • General Counsel
Outside the business
  • Regulatory Bodies (e.g., MHRA, EMA, FDA)
  • Key Opinion Leaders (KOLs) and Scientific Community
  • Investors and Analysts
  • Patient Advocacy Groups
  • Academic Institutions and Research Partners
  • Media and Public Relations

9What you need before you start

Not a wish list. The things you would be expected to already have.

  • Extensive (20+ years) experience in senior R&D leadership roles within the pharmaceutical or biotechnology industry, ideally having led global clinical development programmes.
  • Proven track record of successfully bringing multiple drug candidates through late-stage clinical development to regulatory approval.
  • Deep expertise in at least one major therapeutic area, coupled with a broad understanding of drug discovery and development across various modalities.
  • Demonstrated ability to build, lead, and inspire large, geographically dispersed scientific and medical teams.
  • Exceptional communication skills, particularly in presenting complex scientific and strategic information to diverse audiences, including Boards, investors, and regulatory bodies.
  • Strong understanding of corporate finance, P&L management, and capital allocation within an R&D context.

10What to practise next

Where the job is going, and what to do about it starting this week.

Advanced Omics Data Interpretation (Genomics, Proteomics, Metabolomics)

The volume and complexity of 'omics' data are exploding. You'll need to understand how to interpret these multi-modal datasets to identify novel drug targets, understand disease mechanisms, and stratify patient populations. This moves beyond basic biology to systems biology.

Multi-omics integration · Network biology & pathway analysis · Single-cell sequencing applications · Bioinformatics & computational biology

  • This quarter: Attend executive-level workshops or seminars on advanced omics technologies and their applications in drug development.
  • Next 6 months: Ensure your preclinical and early clinical development teams have the necessary bioinformatics expertise and tools.
  • Next 12 months: Drive strategic partnerships with academic institutions or tech companies specialising in omics data analysis.
  • Regularly: Challenge your scientific teams to integrate omics data more effectively into their research questions.

Quick win: Ask your Head of Research to present a quarterly update specifically on how omics data is driving new target identification or patient stratification in our early pipeline. Make it a regular agenda item.

Digital Health & Remote Patient Monitoring Integration

Clinical trials are becoming more decentralised, and digital health tools are offering new ways to collect real-world data and monitor patients remotely. You need to strategically integrate these into our clinical development programmes.

Decentralised clinical trials (DCTs) · Wearable sensors & digital endpoints · Telemedicine & virtual care platforms · Regulatory considerations for digital health

  • This quarter: Review our current clinical trial portfolio to identify opportunities for DCT or digital health integration.
  • Next 6 months: Invest in platforms and expertise to support decentralised trial capabilities.
  • Next 12 months: Develop a clear strategy for incorporating digital biomarkers and remote monitoring into new clinical programmes.
  • Continuously: Monitor the regulatory landscape for digital health and engage with industry consortia.

Quick win: Pilot a decentralised component in one of our ongoing Phase 2 trials. Start small, learn fast, and demonstrate the benefits to your clinical operations teams.

11Staying current once you are in

What people here do to keep up
  • Regularly engage with leading scientific and medical journals (e.g., NEJM, Lancet, Nature Medicine) to stay at the forefront of medical advancements.
  • Actively participate in major international medical congresses and scientific meetings (e.g., ASCO, AHA, EULAR, EASL) as a speaker, panelist, or attendee.
  • Serve on external scientific advisory boards for academic institutions or biotech start-ups to broaden your perspective and network.
  • Maintain active relationships with key regulatory officials, participating in industry working groups on policy development.
  • Engage with investor relations teams, practising your scientific narrative for diverse financial audiences.
  • Mentor emerging leaders within the R&D organisation, sharing your experience and shaping the next generation.

12The rising capability

The rising capability

Zavmo analysis

What's rising in its place

This is where the work is heading, and the higher pay with it. Get fluent here and the shift stops being a threat and starts being your edge.

AI & Machine Learning in Drug Discovery & Development

AI is fundamentally changing how we discover targets, design molecules, analyse clinical data, and even predict trial outcomes. CMOs need to understand how to strategically embed AI into every stage of R&D to accelerate innovation and improve efficiency.

  • Generative AI for molecule design
  • Predictive analytics for clinical trial success
  • Real-world evidence (RWE) generation with AI
  • Digital biomarkers & wearables integration

Personalised Medicine & Precision Health Strategy

The shift from 'one-size-fits-all' to targeted therapies based on individual patient biology is accelerating. As CMO, you need to define our strategy for genomics, biomarkers, and companion diagnostics to ensure our pipeline is future-proof.

  • Genomic sequencing & interpretation
  • Biomarker discovery & validation
  • Companion diagnostics development
  • Ethical considerations in genetic data

13What you’ll use

What you’ll use

Skills this role draws on

Technical

  • Global Drug Development Lifecycle Strategy
  • Advanced Regulatory Science & Compliance
  • Clinical Trial Design & Oversight (Strategic)
  • Medical Affairs & Scientific Communication

14The pathway

The pathway

How you actually get there, here

How you become one varies far more by country than what one does. This is the UK route. Most people take one of these ways in; the right one depends on where you're starting from.

  1. 1

    EVP, Global Research & Development

    3-5 years as EVP

    Skills to master

    • Enterprise portfolio management, global R&D operations, strategic resource allocation across multiple therapeutic areas, deep regulatory negotiation skills.

    You're ready to move on when

    • Successfully led a major R&D division (e.g., Oncology, Rare Diseases) to multiple regulatory approvals.
    • Demonstrated ability to manage a P&L of over £50M for a complex R&D function.
    • Proven track record of building and leading high-performing, multi-disciplinary scientific teams.
    • Strong external reputation with regulatory bodies and the scientific community.
  2. 2

    Head of Global Medical Affairs

    3-5 years as Head of Global Medical Affairs

    Skills to master

    • Global medical strategy, post-market surveillance, real-world evidence generation, ethical scientific exchange, strong compliance oversight, external stakeholder engagement (KOLs, patient groups).

    You're ready to move on when

    • Successfully built and led a global Medical Affairs organisation.
    • Demonstrated ability to shape market perception through scientific communication and evidence generation.
    • Exceptional relationships with key global opinion leaders and patient advocacy groups.
    • Deep understanding of ethical guidelines and compliance in medical affairs.
  3. 3

    Chief Scientific Officer (CSO) / Head of Early Research

    3-5 years as CSO

    Skills to master

    • Early-stage drug discovery, target identification and validation, preclinical development, platform technologies (e.g., gene therapy, cell therapy), academic and biotech partnership management.

    You're ready to move on when

    • Successfully identified and advanced multiple novel drug candidates into clinical development.
    • Established a track record of groundbreaking scientific publications and patents.
    • Built strong external networks with academic research institutions and early-stage biotech companies.
    • Demonstrated ability to translate cutting-edge science into viable drug programmes.

15Where this role leads

The long view: This role can lead to running a biotech or pharma company as chief executive. It can also lead to work as a venture partner backing early-stage companies, or to global health leadership tackling public health challenges.

The ten Future Fluencies

Zavmo analysis

The credential is what you can do today. These are what keep you valuable.

A qualification proves you can do the job as it's defined today. These ten are what decide whether you're still the obvious person for it in five years. They're the capabilities employers are now writing into senior roles faster than people are learning them. Zavmo weaves them through whatever you study, so you come out with both: the credential and the fluency.

The highlighted ones are the Fluencies your role leans on hardest, from how Chief Medical Officer is actually changing.

Where it leads

Roles this leads to

The record names a next step, but the catalogue has no page for it yet:

  • Chief Executive Officer (CEO)
  • Board Member / Senior Advisor (Public or Private Companies)

How you would learn this

One to one, on the work you already do

A tutor sets the task against your own job and marks the reasoning, at your pace. There is no cohort to fall behind.

A lesson from Provide scientific or technical leadership for a workplace team, worked against Chief Medical Officer.

Provide scientific or technical leadership for a workplace team Level 3

Applied to your work in Chief Medical Officer

This unit aims to equip learners with the skills and knowledge to provide effective scientific or technical leadership within a workplace team. Learners will demonstrate leadership skills, including delegation, motivation, and communication, while understanding the principles of effective leadership and its importance in achieving team goals within a scientific or technical environment.

How the thinking builds
  1. 1 Remember
  2. 2 Understand
  3. 3 Apply
  4. 4 Analyse
  5. 5 Evaluate
  6. 6 Create
An illustration of a Zavmo lesson, built from this role’s own route. The unit, its objective and every criterion above are the awarding body’s own words, not an example.

It is £70 a month, billed monthly. Your free first module is Future Fluency, and you can cancel any time.

See Your Progress Grow Illustration
Chief Medical Officer
  • Global Drug Development Lifecycle Strategy
  • Advanced Regulatory Science & Compliance
  • Clinical Trial Design & Oversight (Strategic)
  • Medical Affairs & Scientific Communication
This is your Mind Palace on learn.zavmo.ai. Every skill above comes from this role's own record, not an example borrowed from another job. A node lights up when you evidence it, and what you build stays yours between jobs. That is the part a course cannot do.

16The detail, folded away

Everything else the record holds

The career branches in full, how AI is already showing up in the day-to-day, and the questions people ask about this job. Here when you want them, out of the way while you decide.

Where it leads next, rung by rung

Where it leads

The career path, and where it branches

Chief Medical Officer is a start, not a ceiling. Each step below asks for new skills and hands back more autonomy.

  1. Chief Executive Officer (CEO)

    5-10 years post-CMO

    Enterprise-wide leadership, full P&L accountability, investor relations, corporate strategy.

    • Enterprise financial modelling
    • Global commercialisation strategy
    • Shareholder value creation
    • Public company leadership

  2. Board Member / Senior Advisor (Public or Private Companies)

    Immediately post-CMO or concurrently

    Strategic oversight, governance, industry influence.

    • Board meeting dynamics and effective contribution
    • Risk management at a multi-company level
    • Strategic due diligence for investments
Working with AI on the job

Working with AI

Where AI is starting to help

Even at the C-Suite, time is your most precious commodity. Imagine cutting through the noise, getting to critical insights faster, and freeing up precious hours for true strategic thinking, not just sifting through reports. AI isn't just for junior roles; it's a game-changer for executive decision-making.

As Chief Medical Officer, you're drowning in data, reports, and strategic documents. AI can act as your personal chief of staff, sifting through vast amounts of information, summarising complex regulatory changes, and even drafting initial communications, allowing you to focus on what only you can do: define the future of our science.

Strategic Insight Synthesis

Feed AI all your internal reports, market analyses, and competitive intelligence. It'll summarise key trends, identify emerging threats, and highlight strategic opportunities, giving you a concise, actionable briefing in minutes, not days. Think of it as a super-powered analyst working 24/7.

Regulatory Intelligence & Risk Assessment

AI can continuously monitor global regulatory updates (MHRA, EMA, FDA, etc.), flag changes relevant to our pipeline, and even draft initial assessments of their potential impact. This means you're always ahead of the curve, ready to adapt our strategy before issues become crises.

Executive Communication Drafts

Need to draft an investor update, a board presentation summary, or a public statement on a clinical trial outcome? AI can generate initial drafts, ensuring tone, key messages, and compliance are aligned, saving you hours of writing and editing. You'll refine, not create from scratch.

Portfolio Optimisation Modelling

Use AI-powered simulation tools to model different R&D investment scenarios, predict pipeline success rates under various market conditions, and optimise resource allocation. This helps you make data-driven decisions on where to put our next £100M, with a clearer understanding of potential outcomes.

Common questions

Common questions

How do you become a Chief Medical Officer?

Common routes in include EVP, Global Research & Development (3-5 years as EVP), Head of Global Medical Affairs (3-5 years as Head of Global Medical Affairs) and Chief Scientific Officer (CSO) / Head of Early Research (3-5 years as CSO). Times vary with prior experience.

Where can a Chief Medical Officer progress to?

This role can lead on to Chief Executive Officer (CEO) (5-10 years post-CMO) and Board Member / Senior Advisor (Public or Private Companies) (Immediately post-CMO or concurrently), depending on the skills you build.

What new skills matter most for a Chief Medical Officer?

Increasingly, AI & Machine Learning in Drug Discovery & Development and Personalised Medicine & Precision Health Strategy. These are the skills our record of this role lists as growing.

Free tools

Want a read on where you stand?

Three free tools, no account needed. Each one ends with a role, a level and a way in.

Read the Zavmo manifesto to understand how you will be taught Meet your tutors

Or try another one

17Where to go from here

Other roles at Level 8

Same depth of qualification, different job. Useful if the work appeals but this particular role does not.

 More jobs in research and development

Stay in the field you know and move sideways rather than up.
If you leave this industry

The experience carries across the life sciences sector, including large pharmaceutical companies, biotechs, contract research organisations, venture capital firms and global health organisations. Knowledge of drug development, regulatory science and medical strategy applies in all of these settings.

This role profile is © 2026 Growth Engineering Technologies Ltd. Built from UK occupational standards and regulated qualification data, and written for Zavmo.

You're not behind. You're right on time. The shift is only just beginning. Your role won't look the same in two years. Be the one who leads the change, not the one it happens to. Start my free Automation Fluency module What happens next: a free account, then we build your plan as you set up. No card. Build your plan, see your roadmap and meet the twelve tutors matched to you. All free. When you're ready to start learning, it's £70 a month, billed monthly. Cancel any time and billing stops.